|
CNOT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.67110000468685E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.72829999703461E-08 |
| Normal-vs-Stage2 |
9.441900E-03 |
| Normal-vs-Stage3 |
7.67160000000322E-05 |
| Normal-vs-Stage4 |
4.797300E-03 |
| Stage1-vs-Stage2 |
6.996400E-01 |
| Stage1-vs-Stage3 |
3.994400E-01 |
| Stage1-vs-Stage4 |
9.579600E-02 |
| Stage2-vs-Stage3 |
9.244400E-01 |
| Stage2-vs-Stage4 |
5.200400E-01 |
| Stage3-vs-Stage4 |
4.169600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62640000356262E-08 |
| Normal-vs-AfricanAmerican |
3.678200E-01 |
| Normal-vs-Asian |
1.700370E-02 |
| Caucasian-vs-AfricanAmerican |
2.960500E-03 |
| Caucasian-vs-Asian |
8.725600E-01 |
| AfricanAmerican-vs-Asian |
1.568000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.96609999964559E-07 |
| Normal-vs-Female |
3.56250000055347E-07 |
| Male-vs-Female |
4.808000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.949420E-01 |
| Normal-vs-Age(41-60Yrs) |
5.23730000479006E-08 |
| Normal-vs-Age(61-80Yrs) |
1.24109999999344E-06 |
| Normal-vs-Age(81-100Yrs) |
3.909800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.971620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.409600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.068000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.838000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.389800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.407000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.221430E-04 |
| Normal-vs-Grade 2 |
3.38760020035522E-10 |
| Normal-vs-Grade 3 |
1.228940E-04 |
| Normal-vs-Grade 4 |
5.322500E-02 |
| Grade 1-vs-Grade 2 |
6.675000E-01 |
| Grade 1-vs-Grade 3 |
1.011650E-01 |
| Grade 1-vs-Grade 4 |
2.964300E-02 |
| Grade 2-vs-Grade 3 |
2.218000E-03 |
| Grade 2-vs-Grade 4 |
1.140420E-03 |
| Grade 3-vs-Grade 4 |
2.195800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.04349895180667E-11 |
| Normal-vs-ccB subtype |
5.76460000000223E-05 |
| ccA subtype-vs-ccB subtype |
1.468490E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.07830000045861E-07 |
| Normal-vs-N1 |
1.006160E-01 |
| N0-vs-N1 |
9.983800E-01 |
|
|
